Display Settings:

Format

Send to:

Choose Destination
    Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1071-4.

    Increased prevalence of Listeria monocytogenes in the faeces of patients receiving long-term H2-antagonists.

    Source

    Department of Gastroenterology, John Radcliffe Hospital, Oxford, UK.

    Abstract

    BACKGROUND:

    Human listeriosis is an uncommon infection caused by the Gram-positive organism Listeria monocytogenes.

    OBJECTIVE:

    To investigate the effects of therapeutic gastric acid suppression on faecal isolation of L. monocytogenes and the incidence of human listeriosis.

    METHODS:

    Five stool specimens from each of 20 patients on continuous H2-antagonist therapy and two faecal samples from each of 47 healthy controls were investigated for the presence of Listeria spp.

    RESULTS:

    A higher faecal isolation rate of L. monocytogenes was detected amongst the patients (20%) compared with the controls (2.1%) (P < 0.025). All subjects with stools positive for Listeria spp. were female, this sex difference being significant in the patient group (P < 0.0036) compared with controls. No patient, however, developed listeriosis.

    CONCLUSION:

    Patients on long-term gastric acid suppressive therapy may be at increased risk of faecal carriage of L. monocytogenes.

    PMID:
    8944368
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk